ClinicalTrialsFinder

Cervical Intraepithelial Neoplasia Grade 2/3 Clinical Trials in Taipei, Taiwan

1 recruitingTaipei, Taiwan, Taiwan

Showing 1–1 of 1 trials

Recruiting
Phase 2

PVX4 for the Treatment of Human Papilloma Virus (HPV)16+ Cervical Dysplasia

Cervical Intraepithelial Neoplasia Grade 2/3Human Papilloma Virus Infection Type 16
PapiVax Biotech, Inc.138 enrolled10 locationsNCT07454915